Stock DNA
Pharmaceuticals & Biotechnology
CNY 14,257 Million (Large Cap)
12.00
NA
2.82%
-0.22
8.15%
1.08
Revenue and Profits:
Net Sales:
4,017 Million
(Quarterly Results - Dec 2025)
Net Profit:
143 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-1.97%
0%
-1.97%
6 Months
-7.26%
0%
-7.26%
1 Year
-12.62%
0%
-12.62%
2 Years
12.02%
0%
12.02%
3 Years
-4.78%
0%
-4.78%
4 Years
-10.58%
0%
-10.58%
5 Years
8.13%
0%
8.13%
Shanghai Shyndec Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.62%
EBIT Growth (5y)
1.93%
EBIT to Interest (avg)
20.12
Debt to EBITDA (avg)
0.27
Net Debt to Equity (avg)
-0.32
Sales to Capital Employed (avg)
0.77
Tax Ratio
20.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.64%
ROE (avg)
10.07%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
1.05
EV to EBIT
6.44
EV to EBITDA
4.14
EV to Capital Employed
1.08
EV to Sales
0.88
PEG Ratio
NA
Dividend Yield
2.81%
ROCE (Latest)
16.82%
ROE (Latest)
8.91%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
4,017.10
2,042.70
96.66%
Operating Profit (PBDIT) excl Other Income
210.30
136.20
54.41%
Interest
0.00
1.30
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
143.20
163.00
-12.15%
Operating Profit Margin (Excl OI)
52.40%
66.70%
-1.43%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 96.66% vs -10.05% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is -12.15% vs -52.97% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
10,937.50
10,863.70
0.68%
Operating Profit (PBDIT) excl Other Income
1,314.00
2,302.20
-42.92%
Interest
0.00
38.90
-100.00%
Exceptional Items
0.00
-10.50
100.00%
Consolidate Net Profit
944.40
1,332.10
-29.10%
Operating Profit Margin (Excl OI)
120.10%
140.30%
-2.02%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.68% vs -9.36% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -29.10% vs 38.10% in Dec 2024
About Shanghai Shyndec Pharmaceutical Co., Ltd. 
Shanghai Shyndec Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






